Cargando…
Pharmacogenomics : challenges and opportunities in therapeutic implementation /
Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
Academic Press, is an imprint of Elsevier,
[2019]
|
| Edición: | Second edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1076873143 | ||
| 003 | OCoLC | ||
| 005 | 20231120010332.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 181203s2019 enka ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d OPELS |d OCLCF |d UKMGB |d LOY |d N$T |d S2H |d OCLCO |d YDX |d OCLCQ |d OCLCO |d AAA |d OCLCO |d OCLCQ |d BRX |d OCLCQ | ||
| 015 | |a GBB8N7581 |2 bnb | ||
| 016 | 7 | |a 019165070 |2 Uk | |
| 019 | |a 1077483989 | ||
| 020 | |a 9780128126271 |q (electronic bk.) | ||
| 020 | |a 0128126272 |q (electronic bk.) | ||
| 020 | |a 9780128126264 |q (electronic bk.) | ||
| 020 | |a 0128126264 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1076873143 |z (OCoLC)1077483989 | ||
| 050 | 4 | |a RM301.3 |b .G45 2019 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a PSAK1 |2 bicssc | |
| 082 | 0 | 4 | |a 615.7 |2 23 |
| 245 | 0 | 0 | |a Pharmacogenomics : |b challenges and opportunities in therapeutic implementation / |c editors, Y.W. Francis Lam, Stuart A. Scott. |
| 250 | |a Second edition. | ||
| 264 | 1 | |a London : |b Academic Press, is an imprint of Elsevier, |c [2019] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, Dec. 4, 2018). | |
| 520 | |a Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar, acogenomic diversity across Latin American populations. With chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation. | ||
| 505 | 0 | |a <P>1. Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications<i></p></i> <p>2. Governmental and Academic Efforts to Advance the Field of Pharmacogenomics<i></p></i> <p>3. Incorporating Pharmacogenomics in Drug Development: Industry and Regulatory Perspectives<i></p></i> <p>4. Translating Pharmacogenomic Research to Therapeutic Potentials<i></p></i> <p>5. Pharmacogenomics in Cancer Therapeutics<i></p></i> <p>6. Pharmacogenomics in Cardiovascular Diseases<i></p></i> <p>7. Pharmacogenomics in Psychiatry Disorders<i></p></i> <p>8. Role of Pharmacogenomics in HIV Infection<i></p></i> <p>9. Role of Pharmacogenomics in Diabetes<i></p></i> <p>10. A Look to the Future: Pharmacogenomics, Pharmacoepigenomics, and System Biology -- Data Technologies of Today and Tomorrow<i></p></i> <p>11. The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging and Pharmacovigilance<i></p></i> <p>12. Pharmacogenomics in Latin American Population<i></p></i> <p>13. Reactive, Point-of-Care, Pre-emptive and Direct-to-Consumer Pharmacogenomic Testing<i></p></i> <p>14. Economic Evaluation of Pharmacogenomic Testing: Lessons from Psychiatric Pharmacogenomics<i></p></i> <p>15. Pharmacogenomics Education and Clinical Practice Guidelines<i></p></i> | |
| 650 | 0 | |a Pharmacogenomics. | |
| 650 | 6 | |a Pharmacog�enomique. |0 (CaQQLa)201-0322837 | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Pharmacogenomics. |2 fast |0 (OCoLC)fst01060245 | |
| 700 | 1 | |a Lam, Y. W. Francis, |e editor. | |
| 700 | 1 | |a Stuart, Scott A., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Pharmacogenomics. |b Second edition. |d London : Academic Press, is an imprint of Elsevier, [2019] |z 0128126264 |z 9780128126264 |w (OCoLC)1028212586 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128126264 |z Texto completo |